Miguel Sieler
Venture Partner @ Truffle Capital
Paris, France
Miguel Sieler is a startup investor at Truffle Capital in Paris. Chairman of the portfolio companies Wittycell, a biotechnology company focused on the development of innovative vaccine adjuvants activating the immune system against infectious diseases and cancer and PlasmaPrime, a company specialised in advisory and training in blood transfusion worldwide.Served in various senior positions with Bayer Groupfrom 1975 to 2008 in Korea, Germany, Belgium, Brazil and France. Former CEO of Bayer Pharma France (1995 to 1998).Former Chairman of Bayer Group France (1998 to 2008).Board member of Nexity SA.Law school graduate from the University of Tubingen, Germany and from Institut d’Etudes Politiques de Paris, France.
Last updated:
For AI agents: llms.txt
About Truffle Capital
Truffle Capital is an independent, European venture capital firm focused on disruptive technologies in IT (FinTech and InsurTech) and Life Sciences (BioTech and MedTech). Truffle Capital aims to support the creation and growth of young innovative companies with the potential to become tomorrow’s market leaders. Chaired by Patrick Kron, alongsidethe company’s founders and CEOs, Philippe Pouletty and Bernard-Louis Roques, Truffle Capital raised over $1 billion and has supported over 75 companies since its creation, in the digital technologies and life sciences sectors.At the end of 2017, Truffle Capital successfully completed the first close of its two new institutional funds, Truffle Financial Innovation Fund and Truffle BioMedTech Fund, as well as the first close of a fund dedicated to the French Reserve Fund (« Fonds de Réserve pour les Retraites » or « FRF »).On May 2019, Truffle Capital is a company of 24 professionals from various nationalities (French, Italian, English, Chinese…), passionated by the trade of financing innovation.
Truffle Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Antoine Pau
Partner
|
|||
|
Faranaz Auliar
Philippe Pouletty Executive Assistant
|
|||
|
Jean-Claude Caducal
CEO Circle, Life Sciences
|
|||
|
Michel Finance
Venture Partner
|
|||
|
Miguel Sieler
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!